Aurinia Pharmaceuticals Inc
AUPH Healthcare Biotechnology
Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024.
- Revenue
- +13.9%
- EPS
- 0.00%
- Free cash flow
- +4.41%
- Total debt
- −30.0%
Quarter to September 2026, against a year earlier
Follow AUPH
Alert me
Aurinia Pharmaceuticals Inc (AUPH) Operating margin
Aurinia Pharmaceuticals Inc's operating margin over the twelve months to 30 September 2026 was 44.8%, up 4.4 percentage points from fiscal 2025 (40.4%). Over the past ten years it has ranged from −23,906.9% (fiscal 2019) to 40.4% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 40.4% | 44.27 |
| FY2024 | −3.84% | 43.63 |
| FY2023 | −47.5% | 36.83 |
| FY2022 | −84.3% | 310.75 |
| FY2021 | −395.1% | (200.55) |
| FY2020 | −194.5% | 23,712.42 |
| FY2019 | −23,906.9% | (11,777.76) |
| FY2018 | −12,129.2% | (869.83) |
| FY2017 | −11,259.3% | 1,927.95 |
| FY2016 | −13,187.3% | (3,153.24) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 40.7% | (7.45) |
| Jun 2026 | 48.2% | (5.48) |
| Mar 2026 | 53.7% | 17.15 |
| Dec 2025 | 36.5% | (5.23) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc compare | 46.5% |
| AUPH Aurinia Pharmaceuticals Inc | 44.8% |
| VCEL Vericel Corporation compare | 8.32% |
| IMNM Immunome, Inc. compare | 0.00% |
| VERA Vera Therapeutics, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| PVLA Palvella Therapeutics, Inc. compare | 0.00% |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | −90.1% |
| CLDX Celldex Therapeutics, Inc. compare | −36,733.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on AUPH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement